Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FOUND: Neutron - You Need To See This

Cathie Wood Just Bet $45 Million on This Beaten-Down Space Stock. Wall Street Sees 70% Upside.

Ark Invest bought more than 705,000 Rocket Lab shares worth roughly $45 million following RKLB stock's plunge from its May high.

Barchart

Rocket Lab's Sell-Off Is Fading—Is It Finally Safe to Buy?

Rocket Lab posted record Q2 revenue and backlog and keeps winning defense contracts, but shares remain volatile as investors await Neutron's fourth-quarter debut before re-rating the stock.

MarketBeat

The Rocket Is Only 1 Piece of Rocket Lab’s Real Strategy

Rocket Lab wants to build, launch, operate, and eventually provide services through satellites, not just sell rockets.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Rocket Lab’s Biggest Breakthrough Has Nothing to Do With Neutron

Rocket Lab delivered record growth and a record backlog before Neutron has even flown, showing the company has become more than a bet on its next big rocket.

Barchart

Rocket Lab’s Highly Anticipated Neutron Flight May Be Delayed. What That Means for RKLB Stock.

Rocket Lab is growing fast, with a record backlog and rising revenue, but a possible Neutron delay is weighing on RKLB stock. So, where does the stock go from here?

Barchart

Rocket Lab’s Record Quarter Still Left Investors Waiting on Neutron

Rocket Lab posted record Q2 revenue and backlog with over $1 billion in new contracts, but shares fell after softer Q3 margin guidance amid heavy Neutron development spending.

MarketBeat

Rocket Lab Reports Earnings Tonight: What Do Prediction Markets Say About Neutron Launches in 2026?

Rocket Lab Corp. (NASDAQ:RKLB) reports second-quarter earnings Monday after the close, with investors listening for an update on Neutron.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Rocket Lab Lands a Wave of Contracts Ahead of Earnings

Rocket Lab won a $397 million Space Force contract, a record $266 million launch deal, and a commercial deal with iQPS ahead of its Aug. 10 Q2 earnings report.

MarketBeat

5 Space Stocks Face a Brutal Correction: Which Ones Are Still Buys?

After a sector-wide selloff, RKLB, ASTS, RDW, LUNR and VOYG shares are down 50%-72% from highs. Valuations, margins and analyst ratings show which drops reflect real buying opportunities.

MarketBeat

Rocket Lab Has Corrected Nearly 50%. Is It Still Too Expensive?

Rocket Lab shares have fallen over 50% since May after Piper Sandler's Neutral rating cited valuation concerns, even as backlog, contracts, and Neutron progress keep the bull case alive.

MarketBeat

Watch Archimedes burn! Rocket Lab fires up engine for its powerful next-gen Neutron launcher (video)

Rocket Lab recently performed a full-duration static fire test with the engine that will power the second stage of its powerful new Neutron launch vehicle.

Space

Rocket Lab’s Stock Drop Comes With a Bullish Twist

Rocket Lab stock is down 45% from its peak, but a record-fast Space Force launch, Morgan Stanley's $293 bull case, and the Iridium deal highlight bullish fundamentals ahead of Aug. 6 earnings.

MarketBeat

Rocket Lab Just Changed Its Growth Story With One Bold $8B Deal

This blockbuster acquisition gives Rocket Lab something it lacked before.

Barchart

Rocket Lab vs. Redwire: 1 Stock Has the Stronger Growth Story for the Next Decade

The SpaceX IPO may have opened a new chapter for space investing. Between Rocket Lab and Redwire, one has the more intriguing long-term growth story.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Dear Rocket Lab Stock Fans, Mark Your Calendars for June 22

RKLB will be added to the Nasdaq-100 next week.

MarketBeat

Rocket Lab Is Down 24% From Its 52-Week High—Pullback or Problem?

Rocket Lab's 18% pullback from its 52-week high appears to reflect normal consolidation rather than any deterioration in business fundamentals.

Barchart

Despite Positive Developments, Rocket Lab Stock Is a High-Risk Name

Rocket Lab is having trouble with a key rocket.

Barchart

Rocket Lab Stock Is Getting a Major Lift. Investors Are Betting on Its Neutron Launch Later This Year.

Rocket Lab stock is blasting higher as investors bet on the growing demand for Neutron launches, which could position it as a serious competitor in the medium-lift rocket market.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Forget the SpaceX IPO: Why Rocket Lab Is the Smarter Space Stock Buy

SpaceX’s IPO could become one of the market’s biggest events, but history suggests mega IPOs often disappoint after launch. Rocket Lab is taking a different path with growing revenue, expanding capabilities, and a proven launch business.

MarketBeat

The Space Race Just Hit a Bottleneck—Who Benefits?

Blue Origin's grounding of New Glenn after an April 19 mishap tightens an already-constrained launch market, potentially benefiting RKLB, FLY, and LUNR.

Barchart

Does Rocket Lab's $2 Billion Backlog Offset Dilution Concerns?

Rocket Lab’s $190 million hypersonic contract has propelled its backlog beyond $2 billion, capping a busy week that also included an equity raise announcement. Investors need to balance explosive contract growth against fresh dilution pressures.

MarketBeat

Rocket Lab Finds Its Footing as Post-Earnings Support Takes Shape

Rocket Lab is stabilizing after an almost 30% pullback from record-highs, with shares holding key support and potentially forming a higher low.

MarketBeat

RKLB Delivers Record Results, But Neutron Delay Weighs on Shares

Rocket Lab (NASDAQ: RKLB) posted record revenue in 2025, expanded margins, and a $1.85 billion backlog, with strong near-term visibility.

MarketBeat

Rocket Lab Earnings Loom as Neutron Timeline Takes Center Stage

Rocket Lab (NASDAQ: RKLB) shares have pulled back nearly 30% from their highs ahead of a pivotal fourth-quarter earnings report.

MarketBeat

Rocket Lab’s Neutron Hiccup Sparked a Sell-Off—Overreaction or Omen?

Understand why Rocket Lab pulled back from January highs, what the Neutron testing incident means, and the key levels and catalysts investors are watching.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.